Understanding Adverse Event Rates: Percentages and Relative Risk in Clinical Trials

Adverse event rates in clinical trials aren't just percentages-they need to account for time on treatment. Learn how the FDA now requires exposure-adjusted methods like EAIR to reveal true safety risks, and why raw percentages can mislead.

Read More